For young people, learning to manage the condition is so important. There is a wealth of information out there that can help youths...

Oncology products monopolise the list of best-selling drugs. With a huge range of indications that is only growing, therapies become more specific to tumour or cell pathologies and increasing patient numbers. Several oncology products now have ‘blockbuster’ status where sales exceed $1 billion annually. This is relevant for clinical trials as more regulators require evidence of efficacy in comparison to the standard of care, which is likely to be one of the blockbuster produc

November is Lung Cancer Awareness Month 2020 in the UK. According to the NHS, lung cancer is the most common cancer in the world, with...

We are pleased to annonce that we will be attending the Jefferies Virtual London Healthcare Conference! We want to use this opportunity...

The global pandemic has made its presence felt in the world of clinical trials, not least in Phase 1 oncology trials. Vanessa Dekou,...

Webinar: How to identify and manage risks in clinical trial supplies and comparator sourcing CSI hosted a webinar with Xtalks on Monday...

Three vaccines currently in circulation are showing high rates of effectiveness in preventing COVID-19. Pfizer-BioNTech Moderna...

Direct to patient trials have surged in popularity in the wake of the coronavirus pandemic, offering several benefits to patients and...

CSI is attending Outsourcing in Clinical Trials and Clinical Trial Supply Nordics 2021 conference on 26–27 October at Scandic,...

Successful clinical trials need effective supply chain management procedures to make sure risks are identified and managed in a timely...

How can you be sure that your comparator sourcing partner will provide you with the best available solution? How do you know that the...